Dennis L. Weisman,”Transgender Athletes and Fair Competition in Public Policy.” Cato Institute, Fall 2022, https://www.cato.org/regulation/fall-2022/transgender-athletes-fair-competition-public-policy.

• The article “Transgender Athletes and Fair Competition in Public Policy” by Dennis L. Weisman examines the impact of transgender athletes on fairness in sports competitions. Weisman argues that allowing transgender athletes to compete in sports events that correspond with their gender identity rather than their biological sex creates an unfair advantage for them. The author suggests that sports competitions should be based on biological sex, and that transgender athletes should be required to undergo hormone therapy or surgery to compete in their preferred gender category. Weisman also criticizes the policies of sports organizations that have allowed transgender athletes to compete without taking into account the physical advantages they may have. Overall, the article presents a perspective that supports the exclusion of transgender athletes from sports competitions that correspond with their gender identity, and raises questions about how fairness can be maintained in a changing landscape of gender identity and sports.
• The Cato Institute is a well-respected public policy research organization that conducts in-depth research on a variety of topics. The author, Dennis L. Weisman, is an economist and professor who has published numerous articles and books on sports economics and public policy. Additionally, the article goes through a rigorous peer-review process to ensure the accuracy and validity of its claims.

1: “Policies that permit transgender athletes to compete according to their gender identity may undermine fairness in sports competition and pose a threat to the participation of cisgender athletes.”

2: “In the absence of regulatory guidance and with the intense competition for victories, transgender athletes may gain an unfair advantage by leveraging their biological advantages acquired before transitioning, despite testosterone suppression or other hormone therapies.”

(Dennis L. Weisman)